Lijuan Fang

A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells

Shengnan Yu, Jing Zhang, Yongxiang Yan et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of (2<i>E</i>)-3-{2-Butyl-1-[2-(diethylamino)ethyl]-1<i>H</i>-benzimidazol-5-yl}-<i>N</i>-hydroxyacrylamide (SB939), an Orally Active Histone Deacetylase Inhibitor with a Superior Preclinical Profile

Haishan Wang, Niefang Yu, Dizhong Chen et al. · Journal of Medicinal Chemistry · 2011 · 91 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Characterization of Antibodies that Detect Human GFAP after Traumatic Brain Injury

J. Susie Zoltewicz, Dancia Scharf, Boxuan Yang et al. · Biomarker Insights · 2012 · 64 citations · Full text

Medicine, Neurobiology, Neuroscience +11

Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro

Xiaoyan Pan, Pengfei Zhou, Tiejiong Fan et al. · Antiviral Research · 2020 · 63 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Identification of Novel Small-Molecule Inhibitors for Human Transketolase by High-Throughput Screening with Fluorescent Intensity (FLINT) Assay

Mark Du, Janet Sim, Lijuan Fang et al. · SLAS DISCOVERY · 2004 · 37 citations · Full text

Life Sciences, Medicinal Chemistry, Oncology +17